Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Mar 16, 2011
Insider Transaction Report
Form 4
STEVENSON KATHARINE BERGHUIS
Director
Transactions
- Purchase
Common Stock, no par value
2011-03-14$40.59/sh+2,000$81,180→ 5,000 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.57 to $40.61, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.